Revenue estimates for Aker BioMarine ASA (OSL:AKBM) have declined from $2.96 billion to $2.95 billion for the full year 2024 and declined from $2.73 billion to $2.72 billion for 2025 over the past ...

Aker Biomarine AS（AKBM）股吧，股票论坛讨论区，让您和专业Aker Biomarine AS股票投资者一起畅所欲言，分析交流Aker Biomarine AS股票的最新动态，行情走势和交易策略。一起讨论Aker Biomarine AS（AKBM）股票吧。

Explore the detailed Aker Biomarine AS balance sheet to understand the company’s financial health and stability. This page provides a clear breakdown of key metrics, including total assets ...

Aker BioMarine ASA (FRA:1PG) completed a significant transaction in the feed ingredients sector, resulting in a net gain of $214 million. The company paid out an extraordinary dividend of $373 ...

Aker Biomarine AS股票交易用户排名，按用户对Aker Biomarine AS股票价格涨跌走势判断准确度来确定。

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

• Q4 revenue reached USD 52.0 million, a 7% increase YoY, with adjusted EBITDA of USD 7.4 million, up from USD 2.5 million last year. • Full-year 2024 revenue totalled USD 199.0 million, up 1% YoY, ...